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Abstract
Background: It is reported that more than 795,000 people in the United States suffer from
stroke, and almost 87% suffer from ischemic strokes. Stroke impacts the patient's condition
causing adverse effects such as paralysis, weakness, lack of proper balancing, excessive
fatigue, and pain, affecting the quality of life. Atrial fibrillation is the leading cause of
strokes, and they are usually provided with anticoagulant therapy, which helps prevent blood
clots. However, the patient faces difficulty adhering to the treatment process, resulting in
stroke and recurrent hospitalization. This quality improvement project (QIP) aimed to
improve the Knowledge of Patients with Atrial Fibrillation to help Adherence to Use
Anticoagulation to Reduce Stroke Risk in the inpatient setting.
Methods: A survey was designed for the pre-and post-intervention. The survey consisted of
4 demographic and 21 knowledge questions on knowledge and treatment of atrial fibrillation
and patient knowledge about the importance of anticoagulation. Fourteen participants
completed the pre-survey, the educational session, and the post-survey. A 15-minute
evidence-based educational session was conducted in the inpatient setting. The survey
results indicated improvement in the knowledge question responses after the 15-minute
educational session. Knowledge scores from the pre-and post-survey were compared, which
were statistically significant. It is reinforced that an educational intervention can improve
the knowledge of the importance of anticoagulation in stroke prevention in patients with
atrial fibrillation can be improved.
Results: Knowledge scores from the pre- and post-surveys were compared, which were
statistically significant based on the p-value.
Conclusion: These findings indicated that educating patients with atrial fibrillation on the
importance of anticoagulation in healthcare can decrease their stroke risk.
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Chapter I
Introduction
Problem Statement
Stroke prevention is of the principal significance in managing patients with atrial
fibrillation, and oral anticoagulation is related to a substantial decrease in stroke/systemic
embolism and mortality. It is reported that more than 795,000 people in the United States
suffer from stroke, and almost 87% suffer from ischemic strokes, which block the blood
flow into the brain. The condition impacts the patient's condition by enhancing the chance
of adverse effects such as paralysis, weakness, lack of proper balancing, excessive fatigue,
and pain, affecting the quality of life (Boehme et al., 2017). The patient suffering from stroke
is usually provided with anticoagulant therapy, which helps in preventing blood clots.
However, the patient faces difficulty adhering to the treatment process, reducing long-term
adherence to the treatment plan (Ramphul et al., 2021). The following paper will suggest an
educational intervention that can be used to commit anti-coagulate drugs and reduce the
chance of developing stroke. The patient faces difficulty maintaining long-term adherence
to the anti-coagulate drugs, which increases the likelihood of developing further
complications or re-occurrence of stroke.
Similarly, recurrent stroke is also higher, almost 25% of the total cases. It is also reported
that the period between the first-ever and recurrent stroke is mainly from a lack of proper
knowledge, fear of long-term adherence to the treatment process, and enhanced mortality
risk. Long-term nonadherence to drugs also develops due to unfavorable long-term side
effects, the long-term burden of the treatment, and patient refusal to adhere to the medicines
(Patel et al., 2021). The other issues resulting in nonadherence to the treatment process
include medication cost, cost of traveling to avail of the drug, and reimbursement. The
patient also has psychological factors that reduce long-term adherence (Foley et al., 2021).
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The psychological factors are cognitive impairment, psychiatric illness, and depression. The
other issues are age, fear of falls, and bleeding. Hence, a good information and care plan
assessment must be implemented to enhance adherence (Ibrahim et al., 2021).
Background
Osamu et al. (2021) studied the clinician's and patients' perceptions of oral
anticoagulants and those suffering from atrial fibrillation. The study highlighted that atrial
fibrillation increases the risk of developing the Incidence of stroke by 20%, and it also
increases the risk of developing morbidity. However, it is also determined that initially, the
patients are recommended warfarin. After consuming the same, the patients shift towards
other oral anticoagulants. It is also determined that novel anticoagulants are much easier to
use than warfarin, and it is also found to provide fewer challenges for both healthcare
professionals and patients. The study's result highlighted that the clinician considers older
age as the risk factor that increases the risk of developing nonadherence to drugs (Kularni
et al., 2021). The study also highlighted that patients' health and lack of proper medication
beliefs affect adherence. The study also highlighted that lack of appropriate patient support
is vital in enhancing safety, and it is one of the most effective Anticoagulation. The patient
also faces adherence difficulties due to a lack of confidence and experience in safe
Anticoagulation: other medical comorbidities and poor understanding of atrial fibrillation
influence the patient's belief. Hence, adequate self-management is essential, provided by
patient education in improving adherence to anticoagulation drugs and lowering the risk of
developing stroke (Kvarnstrom et al., 2018). Pandya et al. (2017) performed a study to
determine the factors which affect the patient's perception and adherence to anticoagulant
therapy. The study highlighted that the role of oral anticoagulants had been extensively
altered and adhered to by the patient's perspective. The efficiency and safety of utilization
of anticoagulants are highly reliant on the patient's capability to achieve and take these
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multifaceted, speculative drugs. The study's result highlighted that various factors affect
adherence to anticoagulant therapy, including patient-related issues, condition-related
issues, social-economic issues, and health system issues. The elements found to have
adverse effects include a lack of proper monitoring, a lack of appropriate dose adjustments,
and a lack of knowledge, which creates a barrier to long-term adherence to the treatment
process. The other challenges are twice-daily dosing, high cost, and adverse gastrointestinal
disorder. Hence, proper patient education with a mandatory monitoring system can improve
patient safety and long-term adherence to the treatment plan.
Scope of the problem
The prevalence and frequency of Atrial fibrillation are rising equally in developed and
developing countries. It is, therefore, the most important cause of hospitalization, morbidity,
and mortality. The rate and occurrence of atrial fibrillation will increase exponentially in the
upcoming years (Foo). Atrial fibrillation is the most frequently experienced cardiac
dysrhythmia in the United States and is the main reason for hospitalization, stroke, disability,
and death. The precipitously rising occurrence of atrial fibrillation is primarily attributable
to the maturing of the population. Because atrial fibrillation may be infrequent and
asymptomatic or slightly symptomatic initially, its incidence is hard to determine
(Desphande et al., 2014). It is reported that the occurrence of stroke is increasing daily, is
almost 11.2% and 11.4%, and the event is frequent 12 months. The risk of recurrence was
also between 11% and 15% within the cerebral insult. 87% of the patient is found to be
suffering from ischemic strokes, which also increases the cost of treatment. The condition
also increases the death rate, which is higher in the Hispanic community. The recurrent
stroke rate is also higher, with almost 25% of strokes in the United States. The recovery rate
is also lower due to the lack of suitable treatment options and education (Anghel et al., 2019).
The NOACs (Novel Oral Anticoagulants) do not need anticoagulation watching. Still, given
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that these drugs have a short half-life, it turns out that attempts had to be addressed to
enhance patient adherence and perseverance with therapy (Lip et al. 2018).
Consequences of the problem
A significant degree of medication adherence is of utmost significance for the
effectiveness of anticoagulant treatment. Nonadherence to anticoagulant therapy is precisely
related to cardioembolic issues. The primary benefits of Novel oral anticoagulants over
Vitamin K antagonists are the fast beginning of the action, balanced fixed-dose pattern, and
the lack of the need for checking. Of these elements of Novel oral anticoagulants, outpatient
follow-up visits are low. Due to their short half-life, the effectiveness of Novel oral
anticoagulants may vanish immediately if the dose is skipped. Hence, drug observance is
crucial for Novel oral anticoagulants (Emren et al., 2017). Adherence to anticoagulation is
weak in routine and may be somewhat better with Novel oral anticoagulants (Yao et al.,
2016). The issue can be resolved by providing the patient with proper education in
appropriate awareness. The total cost of providing adequate health education is $100, and
the patient needs to be monitored effectively, which will be required a total cost of $275 to
$ 7963. The telecare system can also be addressed (Raghupathi & Raghupathi, 2020).
Knowledge Gaps
Knowledge about oral anticoagulant therapy can affect therapy results in patients
with atrial fibrillation, and various reasons can restrict the ideal use of oral anticoagulants.
Oral anticoagulants are categorized into the following groups: direct-acting oral
anticoagulants (DOACs), such as dabigatran, apixaban, rivaroxaban, and edoxaban, and
vitamin K antagonists (VKAs), such as warfarin. Data suggests that collective
determination-making with patients is essential in managing atrial fibrillation. Likewise,
patients with atrial fibrillation should be appropriately advised regarding their disease and
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the advantage of oral anticoagulants. Oral anticoagulants are risk-prone drugs, and patient
knowledge is necessary for supporting the sensible use of oral anticoagulants.
Additionally, understanding oral anticoagulant therapy can change therapy results
in patients with atrial fibrillation. Patients with improved knowledge of the danger and use
of oral anticoagulant therapy demonstrate superior loyalty to persons with insufficient
knowledge. Also, patients’ perception of their disease and oral anticoagulant therapy has
been defined to impact anticoagulation control. Reasons that increased results in patients
taking oral anticoagulants consist of improved adherence to dosing schedules,
understanding of the international normalized ratio (INR), management of diet to avoid
interfaces, and checking the side effects of oral anticoagulants (Alajami et al., 2021).
There is a lack of proper information about the effectiveness of patient education, and
hence, adequate assessment before providing education must be done by the healthcare
professionals in providing care. Prevention of stroke will be involved in the study.
Proposal Solution
The patient must be provided with proper knowledge, which will help reduce the false belief
in long-term adherence to the treatment process. The healthcare professionals, in this case,
must access the patient's knowledge and involve them in a proper awareness program, which
helps improve adherence. The patient's condition must be monitored, and the health care
providers must provide appropriate medication information in the patient information form.
The older adult can be involved in various patient groups, which will also help alter their
behavior and act as peer support (Arruzza & Chau, 2021). Hawes (2018) stated that proper
education must be provided based on the patient's condition and fear of drug adherence. The
patient can also be delivered with a motivational interview and correct information about
precautions while consuming the medication. Emergency support needs to be provided to
the patients, which will help overcome the fear, and the patient will be confident in adhering
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to the drug. Information about complications and cost-effective treatment needs to be
provided as well.
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Chapter II
Summary of the Literature
It is reported that more than 795,000 people in the United States suffer from stroke,
and almost 87% suffer from ischemic strokes, which block the blood flow into the brain. It
is reported that cardiovascular disease development is increasing in the United States.
Almost 610,00 new cases of strokes are reported. Nearly 185000 individuals developed
strokes for the second time, which indicates that the reoccurrence of stroke incidence is one
of the significant issues which needs to be resolved through proper public health
intervention. The condition impacts the patient’s condition by enhancing the chance of
adverse effects such as paralysis, weakness, lack of adequate balancing, excessive fatigue,
and pain which affects the quality of life (Boehme et al., 2017). The development of stroke
is one of the leading causes of death in the United States, common among disabled adults.
The development of stroke results in long-term disability. Almost 7 million stroke survivors
reside in the United States, and 25% of the patients recover from their first stroke within the
last 5years. The report also highlights that almost 87% of individuals suffer from ischemic
strokes blocking blood flow into the brain. The long-term development of the stroke
condition negatively impacts the population's health, including fatigue, paralysis,
depression, increased treatment cost, and reduced quality of life. The patient suffering from
stroke is usually provided with anticoagulant therapy, which helps in preventing blood clots.
However, the patient faces difficulty adhering to the treatment process, reducing long-term
adherence to the treatment plan (Ramphul et al., 2021). Atrial fibrillation is a persistent
arrhythmia in clinical practice; atrial fibrillation is an independent risk factor for stroke,
bestowing an additional five-fold risk in Atrial fibrillation patients linked to those in sinus
rhythm and accounts for almost 10-15% of all ischaemic strokes and about one in four
strokes in those aged over 80 years. Additionally, when a stroke happens in connection with
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Atrial fibrillation, patients have significantly larger death, morbidity, disability, and
extended hospital stays (Smith et al., 2009).
The patients are provided with anticoagulant therapy as it helps in reducing blood clotting.
Still, there is a difficulty in long-term adherence to the drugs, which increases the Incidence
of stroke reoccurrence (Patel et al., 2021). The following paper will discuss the importance
of patient educational intervention for improving the patient’s adherence to anticoagulant
drugs. The following article will suggest educational interventions which can be used for
long-term adherence to anti-coagulant medicines and to reduce the chance of developing
stroke. To a lesser extent, oral anticoagulation is used in patients with atrial fibrillation. Most
excellent patients with atrial fibrillation must get long-term oral anticoagulation to reduce
the danger of ischemic stroke and other embolic results. For the most excellent patients, the
advantage of anticoagulation overshadows the related rise in the possibility of bleeding.
Search strategies
Search strategies of the paper targeted finding reliable resources that discussed atrial
fibrillation and the importance of adherence to anticoagulation in preventing stroke. To
reach the goal, several sources were examined and created into a literature review. A search
strategy to find appropriate proof on the subject was recognized to encourage this
intervention as a means to focus on the clinical question. Regulators ensured that the findings
required the most timely and thorough proof to help the practice change over. The search
strategies used for collecting articles are- “Stroke,” “Anticoagulant,” “Patient education,”
“Intervention,” “Fear of reoccurrence,” and “mortality.” The Boolean operators AND and
OR are used for collecting articles which include- “Stroke AND Cardiovascular disease,”
“Stroke AND United States,” “Anticoagulant OR Warfarin,” “Usual Care AND Patient
education,” “Patient education AND Anticoagulant drug,” “Prevention AND Patient
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education,” “Recurrent Ischemic Stroke AND Anticoagulant drug,” “Interview OR Anticoagulant recommendation.” The Boolean operations AND and OR are used for collecting
relevant articles from the search database. The search databases which were used for
collecting relevant articles include- “NCBI,” “Google Scholar,” “PubMed,” “Medline,” and
“CINAHL.” The papers published between 2016 to 2022 and the articles published in
English were included in the study. A total number of 7 papers are included in the study.
Introduction to Atrial fibrillation
Atrial fibrillation (AF) is the prevalent arrhythmia and accounts for one-third of
hospital admissions for rhythm conditions in the United States. The incidence of AF is
around 1% and increases in intensity with age, such that 10% of people over the age of 80
has AF, and roughly 70% of cases of AF are in patients between 65 and 85 years of age.
With the aging of the population, the amount of patients with AF is likely to rise by 150%
by 2050, with more than 50% of AF patients standing over the age of 80. This growing
problem of AF will lead to a greater prevalence of stroke, as the affected role with AF have
a five- to sevenfold more significant risk of stroke than the overall population. Strokes due
to AF have a more authoritarian prediction than in patients without AF.
Furthermore, AF is an individual risk factor for mortality, as seen in the Framingham
population, with an odds ratio of 1.5 in men and 1.9 in women. Vitamin K antagonists (e.g.,
warfarin), direct thrombin inhibitors (dabigatran), and factor Xa inhibitors (rivaroxaban and
apixaban) are all oral anticoagulants that have been FDA accepted for the prevention of
stroke in AF. The CHADS2 and CHA2DS2-VASc scores are the primary tools presently
used to determine the probability of stroke in patients with AF to determine who has the
adequate risk to warrant oral anticoagulation. (Rao et al., 2014b).
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Anticoagulation
The patient faces difficulty maintaining long-term adherence to the consumption of
anticoagulant drugs. The main reasons which increase the chance of nonadherence include
lack of proper medication, lack of appropriate understanding of the drugs, increased risk of
side effects, lack of knowledge and ability to determine the importance of medication
adherence, and fear of the cost of treatment (Hawking et al., 2020). The patient’s certainty
is predisposed by a lack of relevant comorbidities and deprived information in considering
the disorder of atrial fibrillation. Hence, proper self-assessment and self-management plans
must be provided to the patient, which will help lower the reoccurrence of stroke. The cost
of providing health education in the United States will be $100, and proper monitoring of
the patient’s condition needs to be done to reduce the long-term cost of treatment. The most
common contradictions to anticoagulants include uncontrolled hypertension, frequent falls
or blackouts, and the inability to comply with the treatment process (Oliveira-Kumakura et
al., 2019). The patient must be adequately educated about contraindications,
thrombocytopenia, and hypersensitivity. It is also stated that the stroke recurrence rate of
stroke is controversial. It is reported that the rate is found to increase from 7.0% to 20.6%
in the first year and from 16.2% to 35.3% in the next five years, and finally, the rate is found
to increase from 14% to 51.3% in next 10years after the initial period of stroke development.
Stahmeyer et al., (2019) performed a study to determine the frequency and timing of the
recurrent stroke. The study highlighted that stroke is one of the significant causes of death,
increasing the risk of disability. The risk factors that increase the risk of developing stroke
include diabetes, hypertension, and metabolic disorders. The study's result highlighted that
in 2010/2011, the incidence rate was 292 per 100,000-person years, and the standardized
prevalence was 336 per 100000 per person. The risk of occurrence was 3.4% in 90%, 1.2%
in 30 days, 7.4% in 1 year, and 19.4% in 5 years. The reoccurrence of stroke also increased
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the rate from 6.8% to 45%. The study also stated that the patients must receive proper
treatment to lower the stroke unit. Osau et al. (2021) studied the clinician’s and patient’s
perceptions of oral anticoagulants and those suffering from atrial fibrillation. The study
highlighted that atrial fibrillation increases the risk of developing the Incidence of stroke by
20%, and it also increases the risk of developing morbidity. However, it is also determined
that initially, the patients are recommended warfarin. After consuming the same, the patients
shift towards direct oral anticoagulants (DOACs). It is also determined that oral
anticoagulants are much safer than warfarin, and it is also found to provide fewer challenges
for both healthcare professionals and patients. The study's result highlighted that the
clinician considers older age as the risk factor that increases the risk of developing nonadherence to drugs (Kularni et al., 2021). The study also highlighted that patients' health and
lack of proper medication beliefs affect adherence. The study also highlighted that lack of
appropriate patient support is essential in enhancing safety and is one of the most effective
anticoagulation. The patient also faces adherence difficulties due to a lack of proper
confidence and experience in safe anticoagulation. A lack of proper comorbidities and poor
knowledge of understanding atrial fibrillation condition influences the patient’s belief.
Hence, adequate self-management is essential, provided by patient education, to improve
adherence to anticoagulation drugs and lower the risk of developing stroke (Kvarnstrom et
al., 2018). Pandya et al. (2017) performed a study to determine the factors which affect the
patient’s perception and adherence to anticoagulant therapy. The study highlighted that the
role of oral anticoagulants had been extensively altered and adhered to by the patient’s
perspective. The efficiency and safety of utilization of anticoagulants are highly reliant on
the patient's capability to achieve and take these multifaceted, speculative drugs. The study's
result highlighted that various factors affect adherence to anticoagulant therapy, including
patient-related issues, condition-related issues, social-economic issues, and health system
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issues. The negative effects include a lack of proper monitoring, lack of proper dose
adjustments, and lack of knowledge, which creates a barrier to long-term adherence to the
treatment process. The other challenges are twice-daily dosing, high cost, and adverse
gastrointestinal disorder. Hence, proper patient education with a mandatory monitoring
system can be implemented to improve patient safety and long-term adherence to the
treatment plan.
Patient education and anticoagulant drug
Pandya & Bajorek (2017) performed a study to determine the role of oral
anticoagulants and extensive consideration from the perspective of clinicians. The study
highlighted that the effectiveness and safety of using anticoagulants depend upon the
patient's ability to manage the patient's condition and take drugs correctly and at the right
time, which will help lower the chance of developing complications. The study also
highlighted the patient's responsibility to manage high-risk medicines by taking challenges
in managing complex situations. For that, effective patient education is highly essential. The
study's result highlighted that it is necessary to consider five interacting dimensions for
providing proper patient education related to long-term adherence to anticoagulant therapy
among patients suffering from chronic disorders such as stroke. The factors that need to be
considered include therapy-related, condition-related, patient-related, socioeconomic, and
health factors (Bennaghmouch et ., 2019). The study also highlighted that these factors
negatively affect the patient’s daily life, including regular therapeutic drug monitoring,
dietary consideration, and dose monitoring systems. It is also stressed that the patient who
consumes warfarin is reported to have long-term nonadherence to a drug. The study also
highlighted that nonadherence to an anticoagulant medication includes patient perception
and knowledge about the purpose of anticoagulation, lack of proper understanding of the
risk and benefits of the treatment, excessive expectations from care or healthcare providers,

18

and socioeconomic status. The study determined that adequate patient education must be
provided to cardiovascular disease patients to reduce the prevalence of stroke by lowering
barriers such as recommending the patient. The patient education mast comprises
information about regular monitoring of the patient's condition, frequent dosing, information
about dietary considerations, understanding of the proper gastrointestinal condition, and the
importance of determining the side effect, which will help in managing the patient's
condition and making effective decisions related to the adherence towards and anticoagulant
selection.
Reasons for non-adherence toward anticoagulant drug
Park & Jang (2021) highlighted that nonadherence is one of the main contributors to
adverse events that negatively impact the clinical outcome of patients treated with warfarin.
The researcher, in this case, performs the multiple regression analysis to understand the
factors influencing medication adherence among the patient taking anticoagulation drugs.
This study highlighted that the factors that influence adherence include consumption of the
drug for more than three to five years, awareness about the consumption of drugs, including
the side effects and the complications, knowledge about the medication uptakes, and
depression for long-term adherence to drugs. The study also highlighted that self-efficacy
and belief do not influence medication adherence. Still, the patient's most common
medication awareness and commitment are associated with mechanical heart valve
knowledge and depression with the long-term consumption of warfarin. The study also
highlighted that it is essential to provide proper education to the patient to maintain
appropriate continuous management of anticoagulation drugs and deliver the patient with
accurate guidance related to the specific diet which needs to be consumed while taking the
anticoagulant medicine and understanding the red flag areas such as contradiction of diet
and medication with anticoagulation as it is one of the significant factors for increasing the
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self-management strategies among the patient suffering from cardiovascular disease. Yao et
al. (2016) performed a study to determine the effect of adherence to oral anticoagulants on
the risk of stroke and the development of major bleeding among patients suffering from
atrial fibrillation. The study highlighted that compared to warfarin, the consumption of
nonvitamin K antagonist oral anticoagulant is more beneficial as the drug dose, drug
interaction, and monitoring of the patient's condition are much more accessible. The result
of the study highlighted that the rate of nonadherence is higher among patients suffering
from heart failure, transient ischemic attack, diabetes mellitus, vascular disease, and older
adults. Nonadherence is also higher for stroke, intracranial hemorrhage, and bleeding.
Mayet (2016) highlighted that warfarin is a commonly prescribed oral anticoagulant,
but patient nonadherence is also high. The result of the study highlighted the fact that no
such association is evident between the warfarin therapy and the time of dose, and it was
also found that 46% of the patients have higher adherence to this drug. The rate of
nonadherence is most elevated among female patients. Occupational status, such as
employment status, is also found to impact the patient's condition, which increases the
chance of nonadherence. Due to poor education, older adults have lowered adherence, which
needs to be addressed through proper patient education intervention to improve the
anticoagulant drug's likelihood. Ti Chen et al. (2019) aimed to investigate the adherents to
the anticoagulant drug and the factor found to lower adherence. The researcher, in this case,
addresses the aspect which includes clinical variables, demographics, atrial fibrillation,
knowledge, satisfaction with the provided service, severity, perceived barriers, benefits, and
self-efficacy of the patient in adhering to the medication. The result of the study highlighted
that the difference between adherence to the anticoagulation drug warfarin is insignificant,
and the linear regression analysis identified that passive behavior creates a barrier that is
significantly associated with the predictor of anticoagulation adherence. The study also
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highlighted that with every unit increase in the barrier, nonadherence is 0.48. Still, good
self-efficacy and patient education must be provided to the patient, which will help increase
adherence to anticoagulation therapy.
Hence, the patient's education must consist of better self-efficacy, and it will, in turn,
lower the chance of developing stroke recurrence. Salmasi et al. (2019) highlighted that
medication could not be provided without proper patient education. It is essential to deliver
the appropriate care and education related to the medicine usually prescribed to the patient
suffering from cardiovascular disease atrial fibrillation. The study also highlighted that
nonadherence occurs within 1 year to 1.6year. The nonadherence is mostly for certain drugs
such as apixaban, rivaroxaban, and dabigatran. The study also highlighted that inadequate
warfarin increases the risk of nonadherence. Matalqah (2019) stated that patient information
and therapy understanding are essential factors that increase the risk of drug non-adherence.
The study also highlighted that the factors that need to be considered include the patient’s
understanding of the drug, side effects, noncompliance with medication, and cost of
treatment. The study also highlighted that medication counseling and education help better
understand and increase the patient’s acceptance of consuming drugs as it will help lower
the chance of drug overdosing (Mansukhani et al., 2021).
Patient assessment for anticoagulant knowledge
Praxedes et al. (2020) performed the study to assess the patient's knowledge of oral
anticoagulation, determining their adherence and expertise. The research, in this case, was
found to develop response item theory to evaluate the ability with the help of an oral
anticoagulation knowledge test item and to determine the patient's understanding of using
adherence to anticoagulation drugs. The result of the study highlighted that the patient
showed positive knowledge of consuming oral anticoagulation drugs. Still, there were issues
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in understanding the pharmaceutical and drug-food interaction, affecting medication
adherence. The result of the study highlighted that a proper patient assessment, including
patient knowledge, must be done to structure the health educational activity for delivery of
individualized education for the patient recommended with warfarin. Rakhshan et al. (2019)
highlighted that cardiovascular disease increases the death rate among the population, which
needs proper investigation of self-management, including knowledge among patients
suffering from atrial fibrillation. The study's result highlighted that implementing a good
sales management plan helps enhance the treatment and lifestyle in managing atrial
fibrillation. It is the responsibility of the health care professional to assess the patient
knowledge related to various factors such as psychological and social, including the negative
outcome which impacts the lifestyle and enhances the chance of developing atrial
fibrillation.
Treatment options
Vinereanu & Matei (2017) performed a randomized control trial study to determine
the multifaceted intervention to improve the treatment among patients suffering from atrial
fibrillation and consuming oral anticoagulants. It has been determined that atrial fibrillation
is considered irregular and very rapid heart rhythm, also known as arrhythmia, which
ultimately results in blood clotting in the heart and enhances the risk of developing heart
failure, stroke, and heart-related complications. Similarly, anticoagulant medication is
recommended for cardiac arrhythmia patients, which helps prevent blood clots and lowers
the chance of developing serious complications, including heart attack and stroke. The
researcher, in this case, conducted a randomized control trial study and a cluster that was
randomized in the ratio of 1:1 to provide proper quality improvement intervention and usual
care. The intervention group received proper education with frequent feedback and
monitoring, which helped understand the changes among the patients related to the treatment
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of oral anticoagulants from the baseline till the evaluation of the patient's condition after one
year. The result of the study highlighted that 2281 patients from 5 different countries were
included in the study. It was determined that implementing the oral anticoagulant drug
helped increase adherence to the treatment process in the intervention group up to 80%,
which was 68% at the baseline. In the control group, the increase was 64% concerning
67%. Hence, the study determined that implementing multifaceted and multilevel
educational interventions helps improve adherence to oral anticoagulation among patients
suffering from atrial fibrillation. It also increases the risk of developing stroke with a
significant increase in treatment adherence. Raparelli et al. (2017) performed a study to
determine the importance of adhering to oral anticoagulant therapy among patients suffering
from atrial fibrillation. The study highlighted that oral anticoagulation is one of the most
effective interventions that help reduce the thromboembolic risk among patients with
nonvalvular atrial fibrillation. The study highlighted that effective anticoagulation helps
avoid major side effects and adherence to anticoagulation helps provide proper
anticoagulation effect among the patient by reducing the chance of blood clotting. The study
highlighted that recommending the patient with nonvitamin K antagonist oral anticoagulants
is effective and safe. The study highlighted that a proper multilevel approach which includes
patient preferences, variability in adherence, and persistent needs to be considered, and clear
support must be provided to the patient by the health care professional, which will improve
the adherence to the anticoagulation and initiation of adherence can be done through
effective monitoring. The study highlighted that educational programs are one of the easiest
tools to change the patient's behavior. It will also help long-term adherence to the treatment
process by understanding the patient's concerns and recommending proper strategies to
increase oral anticoagulation consumption. Gebreyohannes et al. (2021) performed the study
to determine the effectiveness of implementing proper guidelines to increase adherence to
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anticoagulants among patients suffering from atrial fibrillation. The study highlighted that
clinical guidelines related to atrial fibrillation would help optimize the behavior toward
using proper anticoagulants. It will also help lower the issue of non-adherence to
anticoagulant drugs within the primary health care setting. The researcher, in this case,
conducted a systematic review, and a total of 33 studies were included. All the studies which
were eligible with the search strategy helped in understanding the fact that it is essential to
implement the proper guideline related to the adherence and consumption of anticoagulant
drugs among the patient, which will help in improving the address by the patient and the
involvement of pharmacist in the prescription of drug and providing patient education will
be effective in lowering the incident of stroke. The study also highlighted that collaborative
care, including the exceptional support and pharmacist and understanding of the proper
international guidelines related to medication adherence, will help improve the quality of
care and enhance long-term adherence towards the anticoagulant drug for preventing the
risk of developing stroke. Desteghe et al. (2018) performed the study to determine the
importance of daily monitoring-based feedback to improve adherence to nonvitamin K
antagonist oral anticoagulants among patients suffering from atrial fibrillation and prevent
the risk of developing a heart attack or stroke. The study's result highlighted that the
telemonitoring system's persistent adherence to proper medication was high. The study also
determined that daily monitoring led to patient education helps increase long-term
adherence to the treatment process, and direct feedback further improved the consumption
of anticoagulants. The study also highlighted that the intake of medication was also
significantly higher. The feedback process helped reduce the treatment cost to prevent
stroke, which helped increase trust and long-term adherence towards the anticoagulant
medication system by the patient. Hence, the telemonitoring system is one of the effective
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processes for improving the treatment plan, and it also helps lower the risk of developing
adverse health outcomes.
Vitamin K antagonists- Treatment option
Durand et al. (2020) highlighted that direct anticoagulant is found to be replaced
among patients suffering from stroke or atrial fibrillation. Warfarin consumption is returned
to prevent stroke among patients suffering from atrial fibrillation. The study aims to compare
the safety and efficacy of various anticoagulant drugs, such as apixaban, dabigatran, and
rivaroxaban, versus warfarin for treating stroke patients and preventing atrial fibrillation.
The researcher, in this case, was found to perform a population-based observational study
where the patient suffering from atrial fibrillation initiated with anticoagulant therapy was
included in the study. The researcher, in this case, assessed the primary outcome for
understanding the prevalence of stroke among the included patient. The secondary outcome
that was found to be analyzed in the patient consists of the primary cause of bleeding and
understanding of the mortality and morbidity rate. Lastly, the study also aimed at
investigating systemic embolization. The survey result highlighted that a total number of
128273 patients were initiated with anticoagulant drugs, and almost 128 273 patients were
also found to start warfarin drugs. The study's result highlighted that the patient with direct
oral anticoagulant consumption was reported with a lower level of major bleeding cause.
The mortality rate was also found to decrease among the patient. Hence, in this case, it can
be stated that proper educational intervention must be provided to the patient in consuming
direct oral anticoagulant medication, which will help prevent the chance of developing atrial
fibrillation incidents. Patti et al. (2017) highlighted that the patient suffering from atrial
fibrillation could be provided with nonvitamin K antagonist oral anticoagulation to prevent
the chance of developing various complications, which is often observed among the patient
adhering to warfarin drug.
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The researcher measured the primary outcome of the development of stroke or systemic
embolism, development of major bleeding, intracranial bleeding, and vascular death. The
study highlighted that the Incidence of complications was higher among diabetic patients
than in non-diabetic patients. In this case, proper education and recommendation must be
provided to improve the advent and prevent the chance of developing complications. The
result of the study highlighted that no such interaction between the benefit of nonvitamin K
antagonist oral anticoagulant drugs was found with the occurrence of major
bleeding, stroke, and ischemic stroke. The study results highlighted that the patient
adhering to the nonvitamin K antagonist oral anticoagulation drug was reported to have a
lower death rate than the patient adhering to the warfarin drug. Silverio et al. (2019)
evaluated the safety and efficacy of nonvitamin K oral antagonist drugs versus vitamin K
antagonist drugs among patients suffering from atrial fibrillation. The researcher, in this
case, aimed to assess the primary outcome as the safety and efficacy of the drug and the
development of ischemic embolism and stroke, including significant bleeding in the
patient. The study determined that the risk of developing systemic embolism and stroke was
lowered among patients consuming nonvitamin K antagonist oral anticoagulation compared
to vitamin K antagonists. The study also highlighted that no significant difference in the
group's significant bleeding was evident. The study also highlighted that the nonvitamin K
antagonist oral medication helps reduce the various complications, including fatal
bleeding, intracranial bleeding, and the development of hemorrhage stroke. The study's
result also highlighted that the Incidence of gastrointestinal bleeding was found to be higher
in the group. Hence, proper education about the complications needs to be provided to older
patients suffering from stroke or atrial fibrillation and consuming anticoagulant drugs.
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Motivational interview for improving the anticoagulant consumption
Tzikas et al. (2020) aimed to assess the impact of any educational, motivational
interview in increasing adherence to oral anticoagulation drugs among patients suffering
from atrial fibrillation. The researcher, in this case, was found to provide an educational
intervention with the help of randomized control trial study when the primary outcome was
to understand the effect of Motivational interviewing in improving the overall consumption
of anticoagulant drugs among the patient after one year. The secondary outcome that the
researcher analyzed includes the rate of persistence towards anticoagulant consumption, the
development of various clinical events due to lack of proper drug consumption, and the
treatment gap present among the patient in the one year of follow-up. The attendance rate in
the treatment group was 55% compared to the control group, within a confidence interval of
95%. The adherence rate seen in the treatment group was 55% compared to the control group
within a confidence interval of 95%. The result of the study highlighted that the
Implementation of a proper motivational interview for the patient suffering from atrial
fibrillation and recommended with the anticoagulant drug is effective in improving
adherence to the drug and reducing the chance of developing complications and
development of significant clinical events, including the treatment gap. The result of the
study also highlighted that the story of clinical events was the same in 2 year median period,
which determined that providing the patient with a proper motivational interview helps
improve adherence to anticoagulant drugs.
Tzikas et al. (2020) highlighted that oral anticoagulation is one of the drugs that help deliver
effective thromboprophylaxis. There is limited evidence of adherence to anticoagulant drugs
among patients suffering from atrial fibrillation. The researcher, in this case, aimed to assess
the impact of the educational, motivational interview in increasing adherence to oral
anticoagulant drugs among patients suffering from atrial fibrillation. The researcher, in this
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case, performed a randomized control trial study. The primary outcome was to understand
the adherence to the anticoagulant drug in 1 year. The secondary outcome highlighted the
gap in the treatment and understanding of the clinical event that developed in the follow-up
period. The result of the study highlighted that out of the 1009 patients included in the study,
500 participants were involved in the intervention group, whereas 509 patients were found
to be involved in the control group. The study's result highlighted that after one year, 77.2
percent of the patients were found to have greater adherence to anticoagulant drugs after
receiving proper motivational interviews compared to the control group, which was 55%.
The patient in the intervention group of motivational interviews was found to have greater
adherence and persistence after one year than the control group acquiring regular medication
care. Hence, in this case, the study addresses the fact that patient adherence and educational
intervention, including motivational interviews, will help increase compliance with the drug
and prevent the chance of developing an adverse effect such as atrial fibrillation among the
patient-recommended anticoagulant medication. Jingjing et al. (2019) aimed to investigate
the impact of motivational interviews on patients suffering from atrial fibrillation and
recommended anticoagulant drugs such as warfarin. The researcher, in this case, was found
to conduct an observational study by providing proper education to increase adherence to
warfarin in therapy. The result of the survey highlighted the fact that the Incidence of selfmanagement among the patient was found to be increased after discharge, including 1, 3,
and 6 months and the optimal condition was also found to be higher in the treatment group,
which was 76.6 5% in comparison to the observational group which was 68.97%. Hence,
in this case, it can be identified that improving self-awareness by delivering proper
motivational interviews for the patient suffering from atrial fibrillation helps improve
adherence to anticoagulant drugs and prevent the recurrence of atrial fibrillation.
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Technologies for improving the adherence to drugs
Guo et al. (2017) performed the study to determine the impact of mobile health
technology on improving the management of patients suffering from atrial fibrillation by
involving the patient in the care of the process, providing practical education, and
implementing an integrated decision support system. The study highlighted that mobile
health technology is increasing in today's world, especially in healthcare technology, and it
is also proposed for improving the condition of cardiovascular disease. It is noted that the
feasibility of mobile health technology is found to be limited in providing care to patients
suffering from atrial fibrillation. Then effective intervention can be implemented after
conducting advanced research, which will also help increase the use of anticoagulants to a
satisfactory level for improving the quality of life and reducing the long-term cost of
developing the disease. The study highlighted that atrial fibrillation is one of the most
common cardiac arrhythmias, increasing the global health burden. Almost 33.5 million
individuals suffer from atrial fibrillation worldwide. The condition can be controlled by
successful adherence to the anticoagulant drug by the patient. The result of the study
highlighted that 113 patients were randomly assigned to the two groups, while 96 patients
were randomly assigned to the usual care group. The study's result highlighted that 90% of
the patient saw the Implementation of mobile health applications for understanding the
patient preference, providing collaborative care, and providing patient education is found to
be higher and more significant in terms of usual care. The result of the study also determines
that the quality-of-life score was significantly increased in the intervention group. The level
of depression and anxiety was higher among the control group patients, highlighting that
patient education with proper adherence to patient wishes helps improve adherence to
medication, especially anticoagulant drugs, and lowers the long-term treatment cost.
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Interventions
Clarkesmith et al. (2017) performed the study to understand the importance of
educational and behavioral intervention for anticoagulants. The study highlighted the
importance of oral anticoagulation therapy for atrial fibrillation patients as it increases the
risk of developing stroke. The study highlighted that nonadherence to medication increases
the risk of developing stroke or cardiovascular disease, enhancing patient treatment costs
and death rates. The survey result highlighted that a total number of 2246 patients were
included in the study. The study, which focused on self-monitoring, education, and decisionmaking, improved the educational intervention among patients suffering from atrial
fibrillation and recommended anticoagulation therapy. The study stated that educational
intervention helped reduce anxiety and depression among patients by increasing their
understanding of the medication's application and effectiveness. Hence, in this case, a proper
educational intervention needs to be implemented for the patient to improve medication
adherence and lower medication costs. Zhao et al. (2017) performed a study to determine
the factors which influence the medication beliefs and knowledge of warfarin towards
adherence to the medication. The study highlighted that warfarin is one of the medications
that help prevent ischemic stroke among patients suffering from atrial fibrillation. The study
highlighted that medication adherence is an effective intervention for preventing the chance
of developing complications and patients suffering from atrial fibrillation. The study
highlighted that addressing warfarin adherence is essential for improving poor medication
adherence and increases the death rate among the individual. Warfarin non-adherence
includes a lack of proper knowledge about the medication prescribed, clinical knowledge,
demographics, and behavioral factors.
The result of the study highlighted those 188 patients who completed the survey and
the significant risk of the element which resulted in non-adherence to medication, including
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the patient's age, development of cardiovascular disease, and lack of true belief in adherence
towards medicine that negative effect which increases the harmful consequences. Chen et
al. (2019) performed the study to investigate anticoagulant adherence and associated factors
such as clinical variables, demography, atrial fibrillation, and other factors such as
satisfaction with the service, the severity of the symptom, and perceived associated barriers
with the atrial fibrillation. The researcher, in this case, collected data using the questionnaire
as the study aims at collecting the evidence and perception of the patient adhering to the
medication and suffering from atrial fibrillation. The survey result highlighted that 151
patients suffering from atrial fibrillation were included in the study and were recommended
warfarin. The other 98 patients were found to be treated with an oral anticoagulant. The
study highlighted that the difference between the two drugs was significant. The barrier
associated with the non-adherence to medication is self-efficacy in assessing the drug, and
perceived barriers such as the negative belief of developing complications increase the risk
of developing the severe condition. Hence, patient education must be implemented to
enhance self-efficacy and reduce barriers.
Lip et al. (2018) highlighted the innovative strategies to improve adherence to nonvitamin k antagonist oral anticoagulant drugs for preventing stroke among patients suffering
from atrial fibrillation. The study highlighted that stroke prevention is one of the principal
priorities among patients suffering from atrial fibrillation. The recommendation of oral
anticoagulation is associated with a significant reduction in the development of systemic
embolism and helps prevent the mortality rate by reducing the disease. The study highlighted
that vitamin K antagonist is marked as interpatient and interpatient variability. The
therapeutic effect gained through the drug helps lower the chance of atrial fibrillation. The
study highlighted that patient counseling and education help in better management of
anticoagulation, and the Implementation of smartphone technology will act as a reminder
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system for the patient, which will help in delivering education such as drug management
and associated side effects and thereby decreasing the fear among the patient and enhancing
the adherence towards the treatment process. Geary & Euler (2020) performed the study to
determine the importance of feedback and audit intervention for patients suffering from
atrial fibrillation and improve the use of anticoagulants to reduce the chance of
complications such as development stroke and heart attack. The study highlighted that
improving the use of anticoagulants among the patient is challenging, increasing the longterm risk. The suboptimal anticoagulant used is partly due to physician non-prescription. In
this case, it is essential to control the behavior and improve the patient's education to enhance
adherence to anticoagulant drugs through proper feedback and audit. The study's result
highlighted that 94 centers received the intervention, and a total number of 31477 patients
were included in the study. The audit and feedback intervention successfully increased
adherence to the treatment process. The compliance rate increased from 76% to 82% after
implementing the intervention. Hence, the feedback and audit intervention is one of the
practical patient education interventions for improving knowledge and adherence to the
drug.
Contreras et al. (2018) performed the study to understand the strategies to improve
dabigatran adherence to prevent stroke among patients suffering from nonvalvular atrial
fibrillation. The study highlighted that it is essential to assess the importance of educational
and reminder calendar systems for improving therapeutic adherence among patients
suffering from nonvalvular atrial fibrillation. The researcher, in this case, divided the
participants into two groups, with the control group providing usual care and the intervention
group giving support such as healthcare education and using a calendar to provide reminders
for consuming the anticoagulant medication. The study results highlighted that almost 659
patients completed the survey, and the rate of daily compliance was 91.97% for six months
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and 90 1.01 % after 12 months of providing the intervention. The medication adherence
was also found to be increased in this case, and the patient had improved knowledge about
the medication adherence related to the time of drug and the doses, which helped in
preventing the chance of developing complications and helped in changing the behavior by
facilitating the evidence towards medication for controlling the likelihood of developing
stroke. Yao et al. (2016) performed a study to determine the effectiveness of nonvitamin K
antagonists and warfarin in easy dosing, drug interactions, and lack of a proper monitoring
system. The result of the study stated that patient suffering from congestive heart failure,
diabetes mellitus, and hypertension has the highest risk of complications among the patient,
and the non-adherence to medication increases the risk of developing intracranial
hemorrhage can be increased by proper patient education. The study also stated that
adherence to anticoagulant drugs is poor, which needs to be raised by appropriate patient
education.
Bartolazzi et al. (2021) highlighted that oral anticoagulation therapy is one of the
most effective interventions and can be recommended to the aging population due to the
higher prevalence of atrial fibrillation. It has been evident that medication adherence is one
of the main issues among older patients suffering from atrial fibrillation. It requires adequate
health literacy to increase commitment to drugs. The highest prevalence of non-adherence
is among patients with poor socioeconomic status and limited knowledge about drug
adherence. Implementing patient education and improving health literacy will enhance
adherence to medication by understanding the drug's effectiveness in preventing
complications and lowering the long-term treatment cost among the patient.
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Patient education
The patient must be provided with proper knowledge, which will help reduce the false belief
in long-term adherence to the treatment process. The healthcare professionals, in this case,
must access the patient’s knowledge and involve them in a proper awareness program, which
helps improve adherence. The patient’s condition must be monitored, and the nurse must
provide appropriate medication information in the patient information form. The older adult
can be involved in various patient groups, which will also help alter their behavior and act
as peer support (Arruzza & Chau, 2021). Hawes (2018) stated that proper education must
be provided based on the patient’s condition and fear of drug adherence. The patient can
also be delivered with a motivational interview and correct information about precautions
to consider while consuming the medication. Emergency support needs to be provided to
the patients, which will help overcome the fear, and the patient will be confident in adhering
to the drug. Information about complications and cost-effective treatment needs to be
provided as well.
Psychological impediments to adherence include incorrect opinions of illness and
insufficient knowledge of the effect, outcomes, and timeframe of Atrial fibrillation or
attitudes about drugs. By growing the providing of info to patients to assist them in
conveying precise beliefs and insights neighboring Atrial Fibrillation and anticoagulation,
patients may be further able and eager to adhere, in the long period, to treatment
endorsements over-improved kind of the disorder and its’ treatment Clarkesmith et al.
(2017).
The above paper discussed the importance of patient education in increasing
adherence to anticoagulation—the development of stroke results in long-term disability. The
patient suffering from stroke is usually provided with anticoagulant therapy, which helps in
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preventing blood clots. Oral anticoagulation drastically decreases the danger of stroke in
atrial fibrillation patients. Almost 7 million stroke survivors reside in the United States, and
25% of the patients recover from their first stroke within the last 5years. The reoccurrence
of stroke also increased the rate from 6.8% to 45%. It is also highlighted that the patient who
consumes warfarin is reported to have long-term nonadherence to a drug. Occupational
status, such as employment status, is also found to impact the patient's condition, which
increases the chance of nonadherence. Due to poor education, older adults have lowered
adherence, which needs to be addressed through proper patient education intervention to
improve the anticoagulant drug's likelihood. Poor patient-knowledge adjoining Atrial
Fibrillation and its therapy may be a factor in the patient’s readiness to stick to suggestions.
Lastly, the paper highlighted the intervention that can be provided to improve adherence.
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Chapter III
Purpose/PICO Clinical Questions/Objective
Purpose
The study's primary aim is to determine the effectiveness of anti-coagulant drug-related
patient education in preventing the issue of stroke, avoiding long-term hospital costs, and
lowering the chance of developing a stroke reoccurrence.
It has been reported that almost 795,000 individuals residing in the United States are
suffering from a stroke. It is also said that the patient faces difficulty maintaining long-term
adherence to the drug, which increases the re-occurrence of the stroke, and the incidence is
higher among Hispanic men (Boehme et al., 2017). The psychological factors that impact
long-term drug adherence include psychiatric illness, cognitive impairment, and depression.
It has been reported that the average age of non-Hispanic white is 80, and the rate of various
diseases such as obesity, high blood pressure, and diabetes is higher among the Hispanic
population (Ramphul et al., 2021).
It has been reported that the incidence of stroke is increasing daily, and the event is
almost 11.4% and 11.2% in 12 months. The rate is 87% of the population, and the Incidence
of ischemic stroke is increasing, which enhances the cost of treatment. The mortality rate is
also higher among Hispanic men, with 34.2 per 100,000 in 2018. The Incidence highlighted
that 60% of death occurs due to Hispanic cardiovascular disease, and the primary cause of
developing the Incidence is lack of education and poverty. It is also stated that the countries
with the highest Hispanic population have an increased rate of uninsured individuals and
have limited access to healthcare settings (Patel et al., 2021).
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This purpose offers a groundwork for the building of a clinical PICO (population,
intervention, comparison, and outcome) question to lead the expansion of this quality
improvement project. Specifically, the following PICO question is suggested:
PICO Clinical Question
“Does the implementation of the proper patient education plan, such as providing knowledge
with the help of educational materials for patients with atrial fibrillation for increasing the
adherence towards anticoagulant drugs, help decrease the risk of stroke and reoccurrence
and lower the non-adherence towards the anticoagulant drugs?”
The PICO elements involved in this question can be illustrated as follows:
P(population)- The population will involve patients admitted to the hospital with the
diagnosis of atrial fibrillation and on an anticoagulant drug. The study will address men and
women with atrial fibrillation between 30 to 75 years.
I(intervention)- Educational program regarding the importance of anticoagulation to
patients admitted to the hospital with atrial fibrillations, assessing patients’s level of
knowledge and appreciation for the importance of stroke prevention. Patient education
enhances patient safety and increases observance of anticoagulants even after discharge.
C(comparison)- Comparing the baseline knowledge of patients undergoing education with
the post-education knowledge regarding the importance of anticoagulation in an inpatient
unit. Recognizing the importance of Anticoagulation in these patients will improve the
quality of care for our patients and community. The usual care process includes a standard
recommendation for anticoagulant drug use. The information will be provided in a voiceover PowerPoint presentation.
O(outcome)- increased patients' knowledge regarding the importance of anticoagulation in
patients with atrial fibrillation and evaluated a strategy to facilitate when appropriate after
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education intervention. The intervention outcome includes improving patient understanding,
and adherence to the drug will increase related to dose and mechanism. The men and women
with atrial fibrillation will have a positive experience after involving in the educational plan.
The follow-up process will improve the patient’s condition and lower the risk-taking
attitude.
Objectives
This quality improvement project's primary objective is to improve atrial fibrillation
patients' knowledge of the importance of adherence to anticoagulation to prevent stroke.
SWOT Analysis
A Strength, Weakness, Opportunities, and Threats (SWOT) analysis was used to assist
with managing this quality improvement project.
Strengths
Strengths of the organization include serving the cardiac population. The inpatient setting is
in an area with many atrial fibrillation patients, and the hospital is an academic facility that
admits various patients. The inpatient setting and the cardiologist are open to new strategies
to improve knowledge of atrial fibrillation patients in stroke prevention. It is also stated that
the organization aims to implement an appropriate consideration for the vulnerable
population by partnering with other healthcare centers, which helps in implementing
affordable care and educational intervention such as providing education based upon the
understanding of the patient and in the local language. The hospital staff, physicians, and
nurse practitioners are approachable, friendly, welcoming, and open to learning. The clinical
and administrative team supported new evidence base practice and were very supportive of
conducting the DNP intervention in the hospital. The hospital admits a wide range of cardiac
patients.
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Weaknesses
Weaknesses of the organization include how much work the nurse practitioners and
physicians do in their day-to-day roles may impede them from completing the pre- and postsurvey and not being able to provide the educational session. Each nurse practitioner and
physician sees approximately twenty to twenty-five patients daily, and the providers in the
health care team have to round on all their assigned patients. If it’s a hectic day, the
participants may not be able to complete the pre-and post- survey nor attend the educational
session on time. On the other hand, as they are in acute care settings, most patients are sick
and unable to do pre-test, attend educational interventions, and post-tests.
Opportunities
Opportunities for this study include educating the healthcare staff in inpatient settings
improve atrial fibrillation patients' knowledge of adherence to anticoagulation to prevent
stroke. The educational presentation will assist in bringing awareness to health care about
the importance of patients' understanding of anticoagulation in stroke prevention. In the
medical setting, how this can prevent recurrent hospitalization and morbidity. This
educational session will allow participants to learn more about why anticoagulant adherence
is essential in the atrial fibrillation population.
Threat
Possible threats include potential participants unwilling to participate due to their
acute clinical conditions. Not having enough participants to attend the educational session.
Depending on the severity of the clinical situation, if they are very sick, there might not be
many participants attending the academic session
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SWOT Analysis of the Acute care Inpatient setting
Strengths
•

The hospital conducts research and
is open to new evidence-based
practice.
• The hospital is a teaching facility.
• The hospital cares for majorities of
cardiac and neuro patients.
• The hospital and administrative
staff are very welcoming.
Opportunities
•

•

•

•

The healthcare staff will be more
aware of the importance of
anticoagulation knowledge in
stroke prevention in the healthcare
setting.
Better understand the importance
of HIV screening in this
community.
How lack of anticoagulation
knowledge in atrial fibrillation can
prevent adherence to
anticoagulation resulting in a
stroke
Participants will get education on
anticoagulation medicine.

Weaknesses
•

Healthcare staff’s daily
routine/workload may hinder them
from completing the pre-and postsurvey.

Threats
•

Unwilling to participate due to their
acute clinical conditions
Participants not attending
educational sessions due to that day
being a busy day with tests and
procedures.
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Chapter IV
Definition of Terms
Improving Knowledge of Patients with Atrial Fibrillation will Help Adherence in Using
Anticoagulation to Reduce Stroke Risk: A Quality Improvement Project. It is
essential to determine the meaning of the following terms as it is associated with
quality improvement projects such as Anticoagulant drugs, atrial fibrillation,
stroke, lack of proper knowledge, and educational plan.
1. Atrial fibrillation is considered irregular and rapid heart rhythm that results in blood clots
and increases the risk of heart failure, stroke, and other heart-related complications. Atrial
fibrillation is shared among patients with atherosclerosis and hypertension. Linares et al.
(2020) performed a study to determine the prevalence of atrial fibrillation among the
Hispanic population in the United States. The study highlighted that the Hispanic
population suffers from a higher rate of atrial fibrillation, and the issue is higher among
Hispanics, Puerto Rican, and Dominicans. The study also stated that the population with a
higher incidence of renal disease, hypertension, diabetes, and left ventricular hypertrophy.
Hence, the population requires proper attention and effective health education to improve
its quality of life (Morgan et al., 2018).
2. Anticoagulant drugs are medication that helps in preventing the development of blood
clots and lowers the risk of developing heart attacks and strokes. The drugs are found to
work by disrupting the blood clots, also known as blood-thinning (Sunkara et al., 2016).
These drugs are recommended for patients with blood clotting, aortic valve replacement,
atrial fibrillation and thrombophilia, and antiphospholipid syndrome. Oral anticoagulants
are categorized into the following groups: direct-acting oral anticoagulants (DOACs), such
as dabigatran, apixaban, rivaroxaban, and edoxaban, and vitamin K antagonists (VKAs),
such as warfarin.
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3. Ischemic stroke develops when the blood supply to the various part of the brain is reduced
or interrupted, and it also prevents the tissues from getting nutrients and oxygen.
4. The patient education plan is needed in this case to help address the predisposing factors
and the primary reason for non-adherence. The lack of education related to health outcomes
and non-adherence to drugs includes- a lack of proper access to the treatment process, a lack
of appropriate care plan, and long-term cost or lack of good follow-up process. The lack of
adequate education and knowledge enhances the death rate or increases the chance of stroke
reoccurrence (Kuriakose & Xiao, 2020).
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Chapter V
Conceptual underpinning and theoretical framework of the project
Health belief model
The theory that can be implemented in this case to address the anticoagulant medication
includes the health belief model. The health belief model helps address the individual’s
beliefs, barriers, and susceptibility, which is essential to implementing proper education.
The health belief model has six stages: pre-contemplation, contemplation, preparation,
action, and maintenance. The model has four core components: perceived susceptibility,
perceived severity, perceived barriers, and perceived benefits. The intervention will help
address the patient's need, and thereby the intervention will help improve trust and prevent
the chance of developing complications (Heid et al., 2016). The health model will help me
in addressing the need of the patient. The health belief model will help address the level of
awareness associated with the anticoagulant drug and help determine the effectiveness of
the care process. The model, in this case, includes the determination of the patient issue,
which is a lack of proper awareness, accessibility, and trust between the patient and the
caregiver. Azadbakht et al. (2022) stated that an appropriate health plan promotion helps
improve patient care as it helps determine the associated factor with applying the health
belief model. The study indicated that health belief meaningfully affects health, encouraging
self-care performances. The study determined that the health belief model helps define the
educational level, age, associated factors, perceived barriers, perceived severity, and selfefficacy as it is associated with the determinants of behavior. Hence, the issue identified by
the health belief model will help implement a proper educational plan. It is also essential to
address the patient’s condition by understanding the experience and issues. Salmsi &
Loewen (2020) stated that it is necessary to determine the experience faced by atrial
fibrillation to address the need for anticoagulant therapy. The result of the study highlighted

43

that the six themes identified in this case include the importance of identifying the reason
for discontinuation of the treatment, determining the patient's attitude, and its relationship
with changes. These challenges are associated with medication intake, patient limitations
due to decision-making, and inadequate education and follow-up. The study highlighted
limited knowledge related to medication related to negative attitudes and challenges in
understanding the proper drug dosage. Appropriate counseling patient programs and patient
education plans must be implemented for the Hispanic patient suffering from stroke related
to the consumption of anticoagulant drugs, which will help lower the Incidence of hospital
readmission or development of emergency conditions due to re-occurrence of stroke
(Melkamu et al., 2021).
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Chapter V1

Methodology
The study aims to determine the effectiveness of patient education in
improving adherence to the anti-coagulant drug among patients with atrial fibrillation.
Study Design
This quality improvement (QI) project evaluated patients' knowledge of the
importance of adherence to anticoagulation and preventing stroke. Evidence-based literature
was used in the creation of the surveys and educational presentations. The pre-and postsurvey contained five demographic questions asking participants their gender, age, race, and
length of anticoagulation. The knowledge section had fifteen questions based on the
literature review articles for this QI project. Participation in this quality improvement project
was voluntary, and the data collected was kept confidential and password protected. The
questionnaire provided information on the purpose of the QI project, information, and a
recruitment letter informing potential participants that completion of the pre-survey
questionnaire means that they consent to participate in the QI project.
Setting
This quality improvement project was conducted in the Inpatient healthcare setting
at Florida. The hospital serves a diverse population. The hospital provides superior health
care to persons for all the patients accessing the care without considering their race and
ethnicity, faith, sexual alignment, and socioeconomic standing. Society strives to deliver
care to every patient while encouraging respect, dignity, and truthfulness. Hospital has an
extensive cardiology department and currently cares for a wide range of cardiac patients.
Sample
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Pre- and post-survey participants included patients with Atrial Fibrillation at the inpatient
settings. More specifically, the pre-survey had a total of atrial fibrillation patients (n=14),
Male (n=7), female (n=7), aged above 50 (n=14), and being on an anticoagulant for 0-1 year
(n=7), 1-5 year (n=2), > 5 years (n=3), ethnicity white (n=8), black (n=4), Hispanic (n=2).
The post-survey included the same population.
Intervention
The DNP candidate delivered an evidence-based educational session in the inpatient setting.
The DNP candidate developed an educational PowerPoint presentation for the participants.
The presentation contained graphics, text, and charts. Literature review articles were used
for the creation of this educational presentation. The educational presentation included
information on atrial fibrillation, its causes, symptoms, stroke, types of anticoagulation,
CHA2DS2-Vasc score, management of atrial fibrillation, the difference between NOAC and
warfarin, features of warfarin vs. NOACs, patient education on oral anticoagulation,
practical considerations of oral anticoagulants. The educational PowerPoint was delivered
as a 20–30-minute educational session: the clinical site administrator and DNP candidate
planned the project. The pre-test, educational session, and post-test were conducted in the
patients' room. Before the pre-test, educational session, and post-test, the DNP candidate
obtained consent and a recruitment letter from the participating candidate.
Instruments
The pre-and post-survey was provided in person with the participating candidate. Qualtrics
is a survey system provided by the DNP candidate academic institution. The demographic
section included questions about gender, age, how long they have been on anticoagulation,
and ethnicity. The DNP candidate developed the knowledge questions, and Evidence-based
literature review articles were used to create all the survey knowledge questions. The first
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five questions asked about the knowledge of atrial fibrillation, and the DNP candidate
developed these questions. Evidence-based literature review articles were used to create all
the survey knowledge questions, the next set of questions focused on knowledge of
treatment and the importance of anticoagulation. The DNP candidate in Qualtrics scored the
surveys.
Data collection procedure
Student investigators identified patients with atrial fibrillation through record review during
the admission process and follow-up. Criteria for inclusion include age, diagnosis, and use
of anticoagulation. The student investigator directly approached potential participants
during the hospital admissions. Recruitment took place once patients got admitted to the
floor. Enrollment in the study was entirely voluntary. The DNP student introduced patients
to the study. Once the patient expressed interest, they were provided with a recruitment
letter. The only identifiable information collected was the patients' age, gender, ethnicity,
use of anticoagulation, and diagnosis. At the start of the study, the patient was asked to
complete the Authorization. Participants were informed that they were free to withdraw from
the study at any time without penalty. Potential participants were informed in person that
completing the pre-survey questionnaire meant they consented to participate in this QI
project. Recruitment occurred in person in their hospital room. The participants were told
there was no monetary incentive for participating in this QI project. Participants completed
the pre-survey questionnaire, and the participant's identities remained confidential. After the
pre-test educational session was provided, the post-survey was administered. The DNP
candidate used the pre-and post-survey to analyze and measure whether the participants'
knowledge improved after the educational session; percentages from 0 to 100 were used to
score the surveys.
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Data Analysis
Participants were provided ID numbers (Alphabetical letters were used for each
participant)Paper-and-pencil surveys were secured in a Locked office in the medical record
department at the proposed clinical site. Only investigators will have access to the
information collected, and the principal investigator and the project author will be able to
access the collected data. For the pre-and post-survey, the DNP candidate scored the data
with a percentage from 0 to 100. The DNP candidate calculated the mean and median scores;
scores ranged from 0 to 100.
Qualtrics scored the demographic section. Descriptive statistics were used to calculate all
statistical variables, and the mean and median score percentages were used to compare the
pre-and post-survey. The DNP candidate used the Mann-Whitney U test (Wilcoxon Rank
Sum Test) to obtain p-values to evaluate whether there was no statistical significance
between the pre-and post-survey. An alpha value of 0.05 was used for the statistical test.
Data management
The recorded data will be protected and confidential, but only the principal investigator and
author will have access to the quality improvement project. Identity and information on the
participants will not be included in a future publications.
Protection of human subjects
All investigators in this QI project have completed the Collaborative Institutional
Training Initiative Program (CITI) training program in protecting human research subjects.
Before implementing this QI project, the DNP candidate sought Institutional Review Board
(IRB) approval. Once IRB approval was obtained, the immersion site administrative liaison
was made aware of the coordinating date and time of the educational session. The
participants in person were informed that participation in this QI project is voluntary and
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that completing the pre-survey questionnaire it means that they are consenting to participate
in this QI project. Consent was obtained in person, explaining the details of the QI project.
The participants were informed that it would take 5-10 minutes to complete the pre-survey,
15-20 minutes to complete the educational presentation, and 5-10 minutes to complete the
post-survey. The data collected from the pre-and post-survey was kept private and password
protected in the medical records department in the hospital. Only the research team members
had access to the data gathered from medical records. There will be no identifiable data
presented in publications and presentations.
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Chapter VII.
Results
This quality improvement project aimed to evaluate the impact of providing an
educational session on the importance of adhering to anticoagulation therapy among
patients with Atrial fibrillation to reduce Stroke Risk. This will help the patients increase
their adherence to the anticoagulants so that risk of stroke can be reduced. The evaluation
of educational intervention is done to measure whether the given educational intervention
improves the knowledge of patients with Atrial fibrillation. The quality improvement project
selected fourteen participants who have Atrial Fibrillation; 14 participants took part in the
pretest, and 14 were given educational intervention. These 14 patients participate in the
posttest, and the results are compared. The quality improvement project includes 14
participants with Atrial fibrillation, the knowledge of these participants regarding their
disease was checked before and after the educational intervention, and the result was
compared to evaluate the effectiveness of the educational intervention. It has been observed
that the knowledge of the patients has been enhanced after the intervention.

50

Demographics
Table 1
Pre-Survey Participant Demographic Data
Count (n=14)

Percent (%)

Age
20-30 years

0

0%

30-40 years

0

0%

40-50 years

0

0%

Above 50 years

14

100%

Male

7

50%

Female

7

50%

Gender

How long have you been
treated
for
Atrial
fibrillation?
Less than 1 year

9

1-5 years

2

More than 5 years

3

64.2%
14.2%
21.4%

Race
White

8

57%

Black

4

28.5%

Hispanic

2

14.2%

Haitian

0

0%

Asian

0

0%

Other

0

0%
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The patients’ demographics are shown in Table 1. There were a total of 14 patients
that have taken part in a protest related to Atrial fibrillation. It has been observed that patients
between the ages of 20 to 50 years were not having Atrial fibrillation. All 14 participants
were above 50 years. It is because as people grow older, the heart's function is affected, and
the diseases like hypertension and coronary artery disease also act as major risk factors for
Atrial fibrillation in older adults (Tam, et al. 2019). It is also seen that of 14 participants,
there were seven males and seven females, both above 50 years. Generally, it has been
observed that females are more affected by the disease, but in this study, the number of
males and females was equal. The maximum number of participants receiving treatment for
Atrial fibrillation for less than 1 year. Nine patients were receiving treatment in less than a
year means they were newly diagnosed with the disease and may not have had enough
knowledge about medication adherence. Only two patients had been treated for the disease
between 1 to 5 years, and only three had been treated for the disease for more than five years.
The patients based on ethnicity have shown that white people are the ones who are most
affected by the disease. The data shows that eight patients out of 14 were white people, four
were black, and two were Hispanic. There was not any Asian and Haitian patient with Atrial
fibrillation.
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Table 2
Post-test demographic data of participants
Count (n=14)

Percent (%)

Age
20-30 years

0

0%

30-40 years

0

0%

40-50 years

0

0%

Above 50 years

14

100%

Male

7

50%

Female

7

50%

Gender

How long have you been
treated
for
Atrial
fibrillation?
Less than 1 year

9

1-5 years

2

More than 5 years

3

64.2%
14.2%
21.4%

Race
White

8

57%

Black

4

28.5%

Hispanic

2

14.2%

Haitian

0

0%

Asian

0

0%

Other

0

0%

53

The demographics of patients for the post-test have been displayed in table 2. The
same 14 patients have taken part in the post-test. The participants were shown great
improvement in their knowledge about the medical adherence to anti-coagulations in the
treatment of Atrial fibrillation. It has been observed that patients between the ages of 20 to
50 years were not having Atrial fibrillation. All 14 participants were above 50 years. It is
due to the fact that as people grow older, the function of the heart is affected, and moreover,
the diseases like hypertension and coronary artery disease also act as major risk factors for
Atrial fibrillation in elderly people (Tam, et al. 2019). It is also seen that of 14 participants,
there were seven males and seven females, both above 50 years. Generally, it has been
observed that females are more affected by the disease, but in this study, the number of
males and females was equal. The participants that were receiving treatment for Atrial
fibrillation for less than 1 year were maximum. There were nine patients who were receiving
treatment in less than a year means they were newly diagnosed with the disease and may not
have had enough knowledge about medication adherence. There were only two patients who
had been treated for the disease between 1 to 5 years and only three patients who had been
treated for the disease for more than five years. The patients based on ethnicity have shown
that white people are the ones who are most affected by the disease. The data shows that
eight patients out of 14 were white people, four were black, and two were Hispanic. There
was not any Asian and Haitian patient with Atrial fibrillation.
Table 3
Patients’ knowledge about the importance of adherence to anti-coagulation drugs in
Atrial fibrillation pre and post-test scores
Questions

Pre-test (n=14)

Post-test (n=14)
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1. What is the name of the 4 (28.57%)

14 (100%)

Cardiac arrhythmia you are
diagnosed with?
2. What is atrial fibrillation?

12(85%)

3. What are we trying to 7(50%)

14 (100%)
14 (100%)

prevent when using blood
thinners while treating atrial
fibrillation?
4. Atrial fibrillation is the 15 (75%)
prevalent

arrhythmia

13 (92.8%)

in

clinical practice?
5.

Atrial

Fibrillation 8 (57.14%)

14 (100%)

significantly affects healthrelated quality of life?
6. What is the given name of 12 (85%)

14 (100%)

your blood-thinning drug?
7.

Do

you

know

the 2 (14.2%)

14 (100%)

difference between Warfarin
and NOAC (Novel Oral
anticoagulants)?
8. Why are you on blood 7 (50%)
thinning medication?

14 (100%)
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9.

Patients

with

Atrial 14 (100%)

14 (100%)

fibrillation can stop blood
thinners when they no longer
feel the symptoms?
10. Does blood thinners stop 10 (71.4%)

14 (100%)

Atrial fibrillation?
11. Have you been given 7 (50%)

14 (100%)

enough time during clinical
or hospital visits to discuss
the

importance

of

Anticoagulation?
12. Do you know in addition 5 (35%)
to

the

medications,
additional

13 (92.8%)

blood-thinning
there

are

therapies

for

Atrial fibrillation?
13. Have your healthcare 7 (50%)

14 (100%)

provider educated you on the
importance of the role of
anti-coagulation in Atrial
fibrillation?
14. Do you agree that 13 (92.8%)
minimal adherence to ant-

14 (100%)
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coagulation medicines can
be associated with the worst
outcome and a higher risk of
stroke?
15. When you miss a dose of 14 (100%)

14 (100%)

your Anti-coagulation, is it
ok to double the next dose of
Anticoagulation?
16. Is it acceptable to stop 14 (100%)

14 (100%)

taking Anti-coagulation once
you feel well?
17.

While

on

Anti- 14 (100%)

14 (100%)

coagulation treatment for
Atrial Fibrillation, when you
have a dental extraction,
what will you do?
18.

What

is

the

most 8 (57.14%)

13 (92.8%)

significant adverse effect of
anti-coagulants?
19. Do you know what a 9 (64.2%)

13 (92.8%)

stroke is?
20. Have your doctor used 1 (7.14%)
the CHAD2DS2-Vasc score

8 (57.14%)
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for Atrial fibrillation stroke
risk?
21. Did your healthcare 3 (21.4%)

14 (100%)

provider talk about therapy
in general, about choices
(together with medications
and other treatment options),
symptoms, and risk factors?

Table 4
The statistically significant difference between Pre and post-test scores with the help of
Mann Whitney U test (Wilcoxon Rank Sum Test)
Pre-Test
Sample Size

Post-Test

14

14

Sample Average

41.25

75.65

Sample Median

50.75

98.2

Sample SD

11.75

19.36

P-Value
0.00005117

58

Figure 1
The mean knowledge score about the anticoagulation drugs and atrial fibrillation pre and
post-test
Figure 1 shows that the average score of the patient’s knowledge about adherence to
anticoagulation drugs is low during the pretest. But when educational intervention is given,
it helps improve people's knowledge.
80
70
60
50

Sample Average

40

30
20
10
0
Pre-Test

Post-Test

P-Value

Figure 1 The mean knowledge score

Figure 2
The median knowledge score about the anticoagulation drugs and atrial fibrillation pre
and post-test.
In this figure 2, it can be seen that the median score of the patients is low in the pretest
compared to the score in the post-test. The educational intervention provided to the patient
improved their knowledge.
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Figure 2 The median knowledge score

Patient’s knowledge score about the anticoagulation drugs and atrial fibrillation pre
and post-test scores. The scoring of Pre and Post-test was measured on a scale of 100. Table
3 shows the percentages of the patients who answered the twenty-one questions asked. There
was an increase in the scores after the educational intervention. Figure 1 compares the preand post-test mean survey scores in a bar chart. The difference between the pre-test and posttest means is 41.25% to 75.65%. After the education intervention, the average increase from
the pre-test was 34.4%. To determine whether there was no significant difference
statistically between the pre-and post-test before and after the intervention, the MannWhitney U test (Wilcoxon Rank Sum Test) was utilized. Based on an alpha value of 0.05,
the Mann-Whitney U test result was adequate to be statically significant. Since the p-value
is 0.00005117, the null hypothesis can be disregarded. This result implies that the pre-and
post-tests show a significant statistical difference. The pre-test's median score is lower than
the post-test median score and illustrated in figure 2 with the help of a bar chart. This
difference shows the effect of the intervention on the patients.
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Chapter VIII
Discussion
Demographics
Atrial fibrillation is a kind of cardiac arrhythmia in which the heart beats rapidly and
too fast, resulting in blood clotting and an increased risk of stroke (Seiffge et al. 2019). The
absence of knowledge about adherence to anti-coagulation drugs can increase the chances
of adverse events related to the disease. It has been observed that the condition generally
occurs as people's age increases. People over 50 years of age are mostly affected by this
condition, and the disease affects an equal number of females and males. The age factor is
the most crucial risk factor associated with the disease. The increasing number of cases in
older adults is due to degenerative aging factors like decreased heart function, coronary heart
disease, and hypertension (Smet, et al., 2018). The most common clinically relevant
arrhythmia is atrial fibrillation (AF), and its prevalence is steadily increasing. The
population's aging is, at a minimum, partially responsible for this growth. Much evidence in
the literature supports the rise in the prevalence of AF with age, likely due to multiple
diseases, cardiovascular risk elements, and other variables, including lifestyle modifications
(Smet, et al., 2018). Hypertension and coronary heart diseases are the risk factors for Atrial
fibrillation. When the blood pressure is high, it affects the ability of the heart to pump blood.
The coordination of the chambers of the heart has also been affected, resulting in abnormal
heartbeats (Schwanda, & Gruber, 2019)
The number of patients treated for Atrial fibrillation in less than a year was the most.
The patients treated for the disease in the last 1 to 5 years were only two in number, and the
patients diagnosed more than five years ago were three. The people recently diagnosed with
atrial fibrillation generally do not know much about the disease that causes the lack of
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adherence to the medication, which ultimately affects the patient's health. In table 1, the pretest demographics of the patients are shown. The pretest demographics show that people
receiving treatment for less than one year are more. The educational intervention is given to
the people so that their quality of life can be improved, but how this intervention will work
and what it will be its effects on the knowledge of the people can be measured by doing a
post-test. The results can be analyzed (Obamiro, et al. 2018).
In table 2, the demographics of the patient post-test were shown, and 14 patients took
part in the post-test. In all, nine patients out of 14 have been diagnosed in the last year. In
the post-test, it was observed that people could answer the questions more correctly after the
intervention was provided to them. Earlier in the pre-test, only 50% of the patients knew
that anti-coagulation medications were given to prevent strokes. The ten patients of 14 in
the pre-test did not know the name of the Cardiac arrhythmia they were diagnosed with. In
the post-test, all 14 participants could tell the name of the Cardiac arrhythmia they have.
That was the effect of the educational intervention.
From the demographic data, it can be seen that white people are more likely to have Atrial
fibrillation. There may be genetic factors behind the fact that white people are more likely
to have the disease than black people and other Asian people. The researcher explained that
the risk factors of the disease are present in black people in an equal amount as for white
people. Still, they do not have the illness despite obesity, hypertension, and other
comorbidities (Angiolillo, et al. 2018). So, they concluded that genetic factors might be
responsible for the disease occurring in white people. The demographic data in table 1 and
2 show that of 14 participants, there were not any Asian patients. 8 of 14 patients were white
people, and 4 of 14 were black people having atrial fibrillation. The data also shows the
presence of 2 Hispanic people with the disease. The purpose of the pre and post-test was to
compare the patients' knowledge about their health condition. In the pre-test, it was observed
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that less percentage of people were aware of the basic information regarding Atrial
fibrillation, like which blood thinning drug they have been prescribed, other therapies for
treating the disease, the reason for providing blood-thinning medications to them,
differences between Warfarin and NOAC (Novel Oral Anti-coagulants), function of blood
thinners, and adverse effects of anti-coagulators. In post-test, most of the patients have given
the correct answers to the same questions asked in the pre-test. This directly shows the
effectiveness of the educational intervention.
Knowledge
Scores for the knowledge tests ranged from zero to a hundred. The average score for
the pre-and post-test is shown in a bar graph in figure 1. The average pre-test score was
41.25%, whereas the average post-test score was 75.65%. When the p-value is less than
0.05, as shown in Table 4, the rejection of the null hypothesis can occur, and there is
a statistically significant difference between the pre-and post-test results. The quantity and
percentage of people who correctly responded to the questions on the pre-and post-test are
shown in Table 3. There is a noticeable rise in both the quantity and percentage of
individuals choosing the correct response after the educational intervention. After the
intervention, more people answered correctly to the questions asked. There were 21
questions in total related to atrial fibrillation. It has been observed that people did not know
why it is crucial to adhere to anti-coagulation medications in atrial fibrillation (Angiolillo,
et al., 2018). The difference in the percentage of correct answers can be seen in table 3. In
the pre-test, only a few respondents correctly answered question six; however, after the
educational intervention, an increase in the number of correctly answered questions was
seen. The same pattern can be seen for question 11, where three individuals correctly
responded to the question, and more participants did so after the educational intervention.
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The median scores for the pre-and post-test are shown in Figure 2. The median pretest score was 50.75%, and the post-survey median score was 98.2%. Similar outcomes were
found by (Lo, et al. 2022), who studied the effects of knowledge on atrial fibrillation. This
study's findings can help improve people's adherence to anti-coagulation medications.
Patients' knowledge about their health condition is very important to improve health
outcomes. Atrial fibrillation prevails worldwide, and if people are aware of medical
adherence, it can be prevented and managed well (Ferguson, et al., 2019). In the post-test, it
was observed that people could give answers to the questions more correctly. This was the
result of educational intervention provided to them. People should know what risks are
associated with atrial fibrillation. This study was conducted to see the effect of educational
intervention on patients with atrial fibrillation.
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Chapter IX
Limitations
Several limitations were found in the QI project findings. Several samples were
available, but in acute care settings, many patients were too sick to participate in the
research. For example, Patients with atrial fibrillation who were intubated could not
participate. Another thing I have noted is due to the acute hospital admission; they were in
and out of their room due to acute tests and procedures, which have limited the sampling.
This data collection only took place among AF patients in inpatient settings. The DNP
candidate developed the survey questions from evidence-based literature articles.
Furthermore, the educational session was time limited. There is a possibility that if more
time had been given to provide content on the importance of anticoagulation in atrial
fibrillation, more participants might have been able to attend. All these may restrict the
concept of our findings. The study can also be done in outpatient settings like cardiology
and primary care provider offices, where patients will be more relaxed. Although the rate of
participants was low, a strength of the project is that it was participated in by patients
diagnosed with atrial fibrillation and on anticoagulation. Regardless of these limitations,
these study findings suggest a need for anticoagulation education in atrial fibrillation
patients can improve stroke reduction by providing educational sessions on this topic.
Healthcare providers can reduce stroke risk by educating on the importance of
anticoagulation in atrial fibrillation, enhancing the quality of the care supplied to atrial
fibrillation patients.
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Chapter X
Implications for Advanced Practice Nursing
Advanced practice registered nurses (APRN) today, more than ever before, are
health professionals who interact with patients during inpatient and outpatient clinical
encounters. Nurse practitioners are necessary to make change happen, allowing them to
contribute the best care to their patients. Stroke prevention by applying anticoagulation
therapy was suggested in Atrial fibrillation patients. The probability of Atrial fibrillation
patients acquiring a stroke is five times inflated compared to non Atrial fibrillation
patients.
Knowledge about Atrial fibrillation and stroke prevention is one of the crucial
components that can help patients’ adherence. Healthcare providers should understand
how important it is for patients with atrial fibrillation to adhere to anticoagulation to
prevent stroke. Nurse practitioners should educate patients on various prevention measures
to reduce the likelihood of stroke and other complications.
The following steps for this QI project are for more educational sessions on
anticoagulation adherence in atrial fibrillation patients in healthcare settings. Based on the
data gathered, patients are not provided with adequate information about atrial fibrillation
and the importance of compliance with anticoagulation in stroke prevention. Healthcare
organizations should observe this example in providing patient education. There is a lack
of education and the importance of anticoagulation education in the outpatient setting as
well. Advanced Practice Registered Nurses (APRNs) should target the inpatient and
outpatient settings and evaluate how much education is provided when atrial fibrillation
patients are started on anticoagulation.
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The atrial fibrillation patients can also be provided with educational materials on
the importance of anticoagulation and how it can help prevent stroke. These educational
sessions can be valuable, especially for newly diagnosed atrial fibrillation patients who
have been started on anticoagulation. Anticoagulation educational sessions can also be
included as part of their discharge paperwork in inpatient settings. Making these
educational sessions necessary can aid in enduring the practice change in healthcare
settings. These educational sessions can help initiate awareness of the importance of
anticoagulation in atrial fibrillation patients in the healthcare setting and how this impacts
them from preventing stroke. In addition, we need to make patients aware of the sequel
and treatment of Atrial fibrillation. Hence, the large gap in knowledge about Atrial
fibrillation and stroke prevention be avoided among Atrial fibrillation patients.
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Chapter XI
Conclusion
Atrial fibrillation is one of the most cardiac arrhythmias spotted in clinical practice,
computing for roughly one-third of hospitalizations for cardiac rhythm disturbances. One
top management of Atrial fibrillation implies halting thromboembolic events using
anticoagulants. Atrial fibrillation-associated strokes are more severe than other kinds of
stroke. Atrial fibrillation patients are twofold as likely to become bedridden than patients
with stroke for different reasons and are more likely to die from the stroke. This can be
referred to in the evidence and literature review table, where several articles mentioned the
lack of patient knowledge on the importance of adherence to anticoagulation in stroke
prevention. Some healthcare providers may not adequately teach patients with atrial
fibrillation to comply with anticoagulants. Furthermore, there is a lack of adequate
anticoagulation education in the inpatient and outpatient settings.
This study is helpful because it comes up with a tool that can be used to discover the
extent of patients’ knowledge about Atrial fibrillation disorder, the importance of
anticoagulation, and its relation with the prevention of stroke. To a great extent, additional
studies should be equipped on the inpatient and outpatient setting with larger sample sizes
to evaluate how much education can improve atrial patient's adherence to anticoagulation in
stroke prevention.
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Appendix C
Recruitment letter for Improving Atrial fibrillation Patients Knowledge on how
adherence to Anticoagulation can prevent stroke: A Quality Improvement Project

To the patients (Name)
My name is Rebelee C Jeyasingh, and I am a student from the Graduate Nursing Department
at Florida International University (FIU). I am writing to invite you to participate in my
quality improvement project. The goal of this project is to improve atrial fibrillation patients’
knowledge of the importance of adherence to anticoagulants to prevent stroke. You are
eligible to take part in this project because you have the diagnosis of atrial fibrillation and
on oral anticoagulants.
If you decide to participate in this project, you will be asked to complete and sign a consent
form for participation. You will complete a pre-test questionnaire, which is expected to take
approximately 10-15 minutes. Then, you will be presented with an approximately 20minute-long educational presentation. After completing the educational presentation, you
will be asked to complete the post-test questionnaire, which is expected to take
approximately 10-15 minutes. No compensation will be provided.
Remember, this is completely voluntary. You can choose to be a part of the study or not and
withdraw at any time. If you would like to participate, please click on the link provided (link
for Qualtrics questionnaire). If you have any questions about the study, please contact me
via email at rjeya001@fiu.edu or call at 786-436-4050. Thank you for your time and
consideration.
Thank you very much
Sincerely,
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Rebelee C Jeyasingh
Appendix E

Pre-Test and Post-Test
The role of an educational intervention to improve adherence in using
Anticoagulation in patients with Atrial fibrillation to reduce Stroke Risk: A Quality
Improvement Project.
Introduction:
This questionnaire is a part of a quality improvement project to address the
importance of patient education to improve adherence to Anticoagulation to prevent Stroke
in Atrial Fibrillation.
Answer to the best of your knowledge. Your response will help to identify
knowledge base and improvement opportunities. The questions are designed to assess your
understanding, knowledge, attitude, and awareness of the importance of Anticoagulation to
prevent Stroke in atrial fibrillation patients.
•

Please do not write down your name or any additional personal info on
this questionnaire

•

Your responses are confidential and will not be shared

•

Your involvement is voluntary and will not change your treatment plan
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Demographic:
Gender: Female____ Male____ Other____ Wish not to disclose____
Age: 20-30 yrs.____ 30-40 yrs.____ 40-50 yrs.____ >50 yrs.____
How long are you being treated for atrial fibrillation? ____<1 Year____1-5 Year____>5
Year
Race/Ethnicity: White____

Black____

Hispanic____

Haitian____

Other____
Knowledge of Atrial Fibrillation
1. What is the name of the cardiac arrhythmia you are diagnosed with?
a) Tachycardia
b) Atrial Fibrillation
c) Ventricular Tachycardia
d) Atrial Tachycardia
e) I don't know
2. What is Atrial Fibrillation?
a) Irregular heartbeat
b) Regular heartbeat
c) Heart dysfunction
d) Heart attack

Asian____
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3. What are we trying to prevent when using blood thinners while treating atrial fibrillation?
a) Symptoms associated with Atrial Fibrillation
b) Stroke
c) Heart Attack
d) Hypertension
4. Atrial fibrillation is the prevalent arrhythmia in clinical practice?
a) True
b) False
5. Atrial fibrillation significantly affects health-related quality of life?
a) Disagree
b) Agree
Knowledge of Treatment
6. What is the given name of your blood thinning drug?
a) Eliquis
b) Pradaxa
c) Xarelto
d) Coumadin
e) Lovenox
f) I don’t know
7. Do you know the difference between Warfarin and NOAC (Novel Oral Anticoagulants)?
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a) Yes
b) No
8. Why are you on a blood thinning medication?
a) It significantly reduces the risk of Stroke
b) Prevent heart attacks
c) Control the heart rate
d) Use to lower Blood pressure
9. Patients with Atrial fibrillation can stop blood thinners when they no longer feel the
symptoms?
a) Yes
b) No
10. Does blood thinners stop atrial fibrillation?
a) Yes
b) No
11. Have you been given enough time during clinical or hospital visits to discuss the
importance of Anticoagulation?
a) Yes
b) No
12. Do you know in addition to the blood-thinning medications, there are additional
therapies for Atrial fibrillation?
a) Yes
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b) No
Educational Intervention on the importance of Anticoagulation
13. Have your health care provider educated you on the importance of the role of
Anticoagulation in Atrial Fibrillation?
a) Yes
b) No
14. Do you agree that minimal adherence to anticoagulation medicines can be associated
with the worst outcome and a higher risk of Stroke?
a) Yes
b) No
15. When you miss a dose of your Anticoagulation, is it okay to double the next dose of
Anticoagulation?
a) Yes
b) No
16. Is it acceptable to stop taking Anticoagulation once you feel well?
a) Disagree
b) Agree
17. While on Anticoagulation treatment for Atrial fibrillation, when you have a dental
extraction, what will you do
a) I Cannot have the procedure while taking Anticoagulation
b) I should consult cardiology
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c) I Can have the procedure done, and there is no need to tell my dentist
18. What is the most significant adverse effect of Anticoagulants?
a) Stroke
b) Bleeding
c) Nausea
19. Do you know what a Stroke is?
a) Yes
b) No
20. Have your doctor used the CHA₂DS₂-Vasc Score for Atrial Fibrillation stroke risk?
a) Yes
b) No
21. Did your healthcare provider talk about therapy in general about choices (together with
medication and other treatment options), symptoms, and risk factors.
a) Yes
b) No

